This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Here's What to Expect From Unum Group (UNM) Q3 Earnings
by Zacks Equity Research
Unum Group (UNM) Q3 results are likely to reflect higher persistency, increased sales and favorable incidence.
Trean Insurance (TIG) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Trean Insurance (TIG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Enact Holdings, Inc. (ACT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Enact Holdings, Inc. (ACT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Hartford Financial (HIG) to Post Q3 Earnings: What's in Store?
by Zacks Equity Research
Hartford Financial's (HIG) Q3 results are likely to reflect a well-performing Commercial Lines, partly offset by inflationary pressure and auto loss costs that render volatility to margins.
Willis Towers (WTW) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
Willis Towers' (WTW) third-quarter results are likely to reflect the impact of strong client demand for advisory work, new software sales, growth in Medicare Advantage revenues, expansion of local portfolios and lower expenses.
Do Options Traders Know Something About Enact Holdings (ACT) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Enact Holdings (ACT) stock based on the movements in the options market lately.
Will Enact Holdings, Inc. (ACT) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Enact Holdings, Inc. (ACT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Fifth Third Bancorp (FITB) Q3 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Fifth Third Bancorp (FITB) delivered earnings and revenue surprises of -5.10% and 0.93%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Why Is Prudential (PRU) Down 1.1% Since Last Earnings Report?
by Zacks Equity Research
Prudential (PRU) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is Encore Capital Group (ECPG) Outperforming Other Finance Stocks This Year?
by Zacks Equity Research
Here is how Encore Capital Group (ECPG) and Enact Holdings, Inc. (ACT) have performed compared to their sector so far this year.
Why Is MetLife (MET) Down 0.7% Since Last Earnings Report?
by Zacks Equity Research
MetLife (MET) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Lincoln National (LNC) Q4 Earnings Miss on Higher Benefits Costs
by Zacks Equity Research
Lincoln National's (LNC) cash and invested cash at fourth quarter-end more than doubles from the 2020-end level.
Allstate (ALL) Q4 Earnings Beat on Health & Benefits Performance
by Zacks Equity Research
Allstate's (ALL) cash balance more than doubles at fourth quarter-end from 2020-end.
Should You Retain Assurant (AIZ) Stock in Your Portfolio?
by Zacks Equity Research
Mobile subscriber growth, solid capital position and effective capital deployment continue to drive Assurant (AIZ).
Should You Retain EverQuote (EVER) Stock in Your Portfolio?
by Zacks Equity Research
EverQuote (EVER) is poised to benefit from improvements in traffic volumes and monetization, improved guidance and sufficient liquidity.
Is Enact Holdings, Inc. (ACT) Outperforming Other Finance Stocks This Year?
by Zacks Equity Research
Here is how Enact Holdings, Inc. (ACT) and AllianceBernstein (AB) have performed compared to their sector so far this year.
Old Republic (ORI) Benefits From Solid Segmental Performance
by Zacks Equity Research
Solid underwriting results, strong rate increases and a solid balance sheet should continue to support Old Republic (ORI).
Should You Hold MGIC Investment (MTG) Stock in Your Portfolio?
by Zacks Equity Research
MGIC Investment (MTG) is poised to grow on the back of decreasing delinquency rate, higher consolidated investment portfolio, lower leverage ratio and effective capital deployment.
Here's Why You Should Hold Radian Group (RDN) in Your Portfolio
by Zacks Equity Research
Radian Group (RDN) is poised to grow attributable to a strong purchase market, higher monthly premium policy insurance in force and solid capital position.
Spooked About Recessionary Fears? Bet on Sin Stocks & ETFs
by Sanghamitra Saha
These sin stocks and ETFs may prove to be recession-proof.
ETFs in Focus as Consolidation Drives Marijuana Industry
by Sanghamitra Saha
Deals activity has been robust in the marijuana space, paving way for gains in these cannabis ETFs.
Marijuana Stocks & ETFs: What Investors Need to Know
by Neena Mishra
Here is what investors need to know about cannabis investing and the first actively managed pot ETF.
Tilray Earnings Impressive: More Reasons to Buy Marijuana ETFs
by Sanghamitra Saha
Tilray earnings results speak of bullishness, making things better for marijuana ETF investors.
US Marijuana Market Warms Up to Merger Deals: ETFs in Focus
by Sanghamitra Saha
Arizona-based Harvest Health is acquiring Chicago-based Verano Verano for about $850 million in the largest U.S. pot deal, putting these ETFs in focus.
Why Marijuana ETFs & Stocks Have More Room to Run
by Sanghamitra Saha
Marijuana stocks and ETFs are hot this year and can perform better in the coming days.